Atlas · Symbols · Stocks & Shares · LRCX
Equity · United States

LAM RESEARCH CORP LRCX

LAM RESEARCH CORP is a special industry machinery, nec issuer listed as LRCX on NASDAQ. This free Atlas page links SEC CIK 707549, Nasdaq Trader and TradingView NASDAQ:LRCX, related symbols and the workstation route before a full report is run.

At a glance

LRCX public profile

Business

Special industry machinery, nec issuer. Atlas tracks LRCX through its NASDAQ listing record, chart route and source links.

Listing

LRCX trades on NASDAQ. SEC CIK 707549. Chart route NASDAQ:LRCX.

Browse

Nasdaq Trader is the listing identity source for LAM RESEARCH CORP. Atlas files LRCX under USA Stocks and Science & Biotech Stocks for browsing. The canonical public URL is /stocks/LRCX/. The workstation link below opens the fuller research run.

Market Wit preview

Lam Research does not sell vibes; it sells kit and support into the chip-making chain, which is a more demanding audience than most earnings-call poetry can survive. The latest filed numbers give the business a pleasingly unsubtle centre of gravity: $5.84B of revenue, $2.05B of operating income and $1.83B of net income attributable to the parent for the 10-Q period ending 2026-03-29. There is still room for corporate soft focus on the official site, where Lam says its people listen closely across the customer and supplier ecosystem. Fine. In this line of work, listening is not a personality trait; it is how a tool maker avoids building expensive machines for yesterday's fab problem. The filing is the harder voice in the room, and it says demand...

Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for LRCX.

Run full research Go Atlas Pro

Daily answer

What changed for LAM RESEARCH CORP today

Open full report
LRCX daily contextvalidated public digest15 source rail2026-06-20 13:54 UTC

Lam Research's strongest current evidence is not a rumour or a price move; it is the filed operating base. In the 10-Q for the period ending 2026-03-29, the company reported $5.84B of revenue from contracts with customers, $2.05B of operating income, $1.83B of net income attributable to the parent and diluted earnings per share of $1.45. That gives the LRCX story a clear centre: this is an operating semiconductor equipment company with earnings, cash and inventory visible in the SEC rail.

Lam's business sits inside the chip production chain, where customer spending, support revenue and engineering depth matter more than slogans. The official issuer page presents Lam as a company tuned into customers, suppliers and the wider production ecosystem, and the supplied image rail includes a product lifecycle image. That supports the product and service context around the numbers, but it does not prove a new product launch, a new customer win or a fresh sales target.

The latest filed financial facts are substantial. For the 10-Q period ending 2026-03-29, Lam reported $20.79B of assets, $10.21B of liabilities, $10.58B of stockholders' equity attributable to the parent, $4.75B of cash and cash equivalents, $4.40B of net cash provided by operating activities, $583.2M of research and development expense, $4.00B of net inventory and 1.26B diluted weighted average shares outstanding. The 10-Q also says nine-month revenue growth versus the prior-year period was driven mainly by increased Foundry equipment spending by customers and higher customer support revenue, mainly spares revenue.

The chart rail is not supplied in this evidence pack, so this report does not invent candle levels, moving averages or support zones. The market mechanism that can be described from the source rail is operational: Foundry equipment spending, customer support demand, spares revenue, factory efficiency, tariff-related spend, deferred revenue movements, inventory and warranty accruals. Those are the pipes through which the equity story currently has to travel.

What changed in the public file is a steady run of named SEC developments after the April reporting cycle. SEC EDGAR lists two LRCX Form 4 filings dated 2026-06-15, two Rule 144 filings dated 2026-06-12 and 2026-06-11, a Form 4 dated 2026-06-02 and a Form SD dated 2026-06-01. The April 22, 2026 8-K announced financial results for the fiscal quarter ended 2026-03-29, while the April 23, 2026 10-Q supplied the detailed filing rail behind the earnings story.

The limits are just as important as the figures. The evidence does not supply guidance, order backlog, segment revenue, customer concentration, share repurchase data, dividend detail, price action or analyst commentary. A deeper LRCX file would need those sources before making claims about valuation, direction or management intent. For now, the reliable story is cleaner: strong filed earnings, visible cash, sizeable inventory, heavy R&D, Foundry-led demand language and an active SEC disclosure trail.

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
LRCX
Exchange
NASDAQ
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView
Source authority

LRCX evidence rails

Atlas uses the specific public rails available for LRCX: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify evidence routes and tools; no partnership, sponsorship or endorsement is implied.

TradingView chart NASDAQ:LRCX

Atlas has no approved static OHLC cache attached for LRCX yet, so the profile renders the verified TradingView chart route directly and keeps the full-chart link as fallback.

Open full TradingView chart ->

Run an Atlas research workflow on LRCX

FreedomCore Atlas operates research workstation templates for company snapshots, DCF, LBO, KYC, NAV tie-outs, and council-grade equity briefs. Each workflow uses public-source filings and structured prompts.

Open Atlas workstation ->
Atlas Pro

Save LRCX research and exports

Free Atlas users can run full browser research reports from the workstation. Atlas Pro adds 25 custom runs a day, saved research history, email delivery, PDF/CSV exports, and a 25-symbol watchlist. £12/mo founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

LRCX FAQ

What is LAM RESEARCH CORP (LRCX)?LAM RESEARCH CORP is a special industry machinery, nec issuer listed as LRCX on NASDAQ. This free Atlas page links SEC CIK 707549, Nasdaq Trader and TradingView...

LAM RESEARCH CORP is a special industry machinery, nec issuer listed as LRCX on NASDAQ. This free Atlas page links SEC CIK 707549, Nasdaq Trader and TradingView NASDAQ:LRCX, related symbols and the workstation route before a full report is run.

What does Atlas show for LRCX?The LRCX page gives the free Atlas profile for LAM RESEARCH CORP: listing identity, chart route, related symbols, source authority and the workstation route. The chart...

The LRCX page gives the free Atlas profile for LAM RESEARCH CORP: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is NASDAQ:LRCX; the stable page route is /stocks/LRCX/. Visible source links include SEC EDGAR CIK 707549, Nasdaq Trader and TradingView NASDAQ:LRCX. Atlas files LRCX under USA Stocks and Science & Biotech Stocks for browsing.

How often is the LRCX page updated?The /stocks/LRCX/ URL is stable. Atlas updates the free LRCX page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or...

The /stocks/LRCX/ URL is stable. Atlas updates the free LRCX page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or published public answer changes.

Which sources does Atlas use for LRCX?For LRCX, Atlas starts with SEC EDGAR CIK 707549, Nasdaq Trader and TradingView NASDAQ:LRCX. The SEC CIK 707549 route is the issuer filing anchor. Nasdaq Trader...

For LRCX, Atlas starts with SEC EDGAR CIK 707549, Nasdaq Trader and TradingView NASDAQ:LRCX. The SEC CIK 707549 route is the issuer filing anchor. Nasdaq Trader confirms the listed-symbol identity used by the public directory. NASDAQ:LRCX is the chart route shown on the free page. Full workstation reports may add fresh filings, issuer documents, holdings, news, macro context or model-reviewed notes when available.

Can Atlas run a full research brief on LRCX?Yes. The workstation can open LRCX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open LRCX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this LRCX page investment advice?No. The LRCX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a...

No. The LRCX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-06-20. Browse FreedomCore Atlas research notes →